Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07516353

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
143 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
15 Years – 24 Years
Healthy volunteers
Not accepted

Summary

This study aims to design and test a novel, personalized digital intervention-my.naviGATE-for adolescent and young adults (AYA) with cancer. my.naviGATE is a mobile app that provides personalized survivorship education, access to virtual peer navigation, and responsive participant-reported outcomes (PROs).

Detailed description

This multi-center, pilot study aims to design and test a novel, personalized digital intervention-my.naviGATE-for adolescent and young adults (AYA) with cancer. My.naviGATE is a mobile app that provides personalized survivorship education, access to virtual peer navigation, and responsive participant-reported outcomes (PROs). Participants in this research study will be randomized into 1 of 2 study groups: my.naviGATE Group versus Usual Care Group. Randomization means a participant is placed into a study group by chance. The research study procedures include questionnaires or surveys, use of the mobile app for those randomized to the intervention, and qualitative interviews with study personnel for a subset of participants. It is expected about 143 people will participate in this research study. The Hyundai Hope On Wheels Foundation is supporting this research study by providing funding.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmy.naviGATE Digital Tool: A HIPAA-compliant digital health intervention in the form of a mobile application that provides personalized cancer survivorship education based on individual treatment regimens, virtual visits with trained peer navigators, and collection questionnaires/survey responses.

Timeline

Start date
2026-08-20
Primary completion
2028-12-31
Completion
2030-12-31
First posted
2026-04-08
Last updated
2026-04-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07516353. Inclusion in this directory is not an endorsement.